JP2016519101A - オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ - Google Patents

オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ Download PDF

Info

Publication number
JP2016519101A
JP2016519101A JP2016505926A JP2016505926A JP2016519101A JP 2016519101 A JP2016519101 A JP 2016519101A JP 2016505926 A JP2016505926 A JP 2016505926A JP 2016505926 A JP2016505926 A JP 2016505926A JP 2016519101 A JP2016519101 A JP 2016519101A
Authority
JP
Japan
Prior art keywords
another embodiment
omega
composition
treating
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016505926A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519101A5 (enExample
Inventor
レビー，レイチェル
ハダド，ヌリト
セドロブ，タンヤ
ゼルクハ，モリス
サポジニク，マシャ
Original Assignee
ライコレッド リミテッド．
ライコレッド リミテッド．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ライコレッド リミテッド．, ライコレッド リミテッド． filed Critical ライコレッド リミテッド．
Publication of JP2016519101A publication Critical patent/JP2016519101A/ja
Publication of JP2016519101A5 publication Critical patent/JP2016519101A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/035—Halogenated hydrocarbons having aliphatic unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2016505926A 2013-04-04 2014-04-03 オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ Pending JP2016519101A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361808246P 2013-04-04 2013-04-04
US61/808,246 2013-04-04
PCT/IL2014/050329 WO2014162313A1 (en) 2013-04-04 2014-04-03 Anti-inflammatory synergistic combinations comprising omega-3 fatty acid and tomato lycopene

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018224936A Division JP6803898B2 (ja) 2013-04-04 2018-11-30 オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ

Publications (2)

Publication Number Publication Date
JP2016519101A true JP2016519101A (ja) 2016-06-30
JP2016519101A5 JP2016519101A5 (enExample) 2017-05-18

Family

ID=51657661

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016505926A Pending JP2016519101A (ja) 2013-04-04 2014-04-03 オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ
JP2018224936A Expired - Fee Related JP6803898B2 (ja) 2013-04-04 2018-11-30 オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018224936A Expired - Fee Related JP6803898B2 (ja) 2013-04-04 2018-11-30 オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ

Country Status (7)

Country Link
US (2) US9901562B2 (enExample)
EP (1) EP2981256B1 (enExample)
JP (2) JP2016519101A (enExample)
CN (1) CN105407885B (enExample)
AU (1) AU2014246728B2 (enExample)
ES (1) ES2932248T3 (enExample)
WO (1) WO2014162313A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9901562B2 (en) * 2013-04-04 2018-02-27 Lycored Ltd. Anti-inflammatory omega-3 synergistic combinations
CN108354919A (zh) * 2017-12-29 2018-08-03 广东海洋大学 一种用于提高抗氧化功能的不饱和脂肪酸组合物及其应用
CN111053248A (zh) * 2018-10-16 2020-04-24 东莞市维康医疗投资有限公司 一种地龙蛋白口服液及其制备方法
CA3153891A1 (en) 2019-10-09 2021-04-15 Gregory CUMBERFORD Compositions with purified bombyx mori cocoon silk peptide fiber and refined buglossoides arvensis seed oil, and related methods
US11707497B2 (en) 2019-10-09 2023-07-25 Brain Health Holding Llc Methods and compositions with purified Bombyx mori cocoon silk peptide fiber and refined Buglossoides arvensis seed oil providing anti-inflammatory effects and neuroprotection for disease states
EP4041207B1 (en) * 2019-10-10 2026-02-25 Lycored Ltd. Compositions and methods for inhibiting collagen loss
US12582692B2 (en) 2024-01-03 2026-03-24 Hazel's Holistic, Llc Methods and kits for reducing microplastics levels and/or reducing or minimizing microplastics accumulation rates in subjects

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000060417A (ja) * 1998-02-13 2000-02-29 Soc Prod Nestle Sa トッピング付きト―スト
JP2013510095A (ja) * 2009-11-06 2013-03-21 アルコン リサーチ， リミテッド ドライアイの軽減のための栄養サプリメント

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837311A (en) 1993-12-13 1998-11-17 Makhteshim Chemical Works Ltd. Industrial processing of tomatoes and product thereof
WO2001051088A1 (en) * 2000-01-07 2001-07-19 Anthony Cincotta Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
AU2003205737A1 (en) 2002-02-15 2003-09-04 Humboldt Universitaet Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
JP2009537467A (ja) 2006-05-15 2009-10-29 ディーエスエム アイピー アセッツ ビー．ブイ． 前立腺癌に対する新規活性物
KR20090109793A (ko) * 2008-04-16 2009-10-21 홉킨스바이오연구센터(주) 크랜베리 추출물 또는 복분자 추출물을 함유하는건강기능성식품 조성물
JP5778584B2 (ja) 2009-01-19 2015-09-16 ライコード・リミテツド カロテノイドとポリフェノールとの相乗的組み合わせ
US20110008901A1 (en) 2009-07-07 2011-01-13 Kiernan Urban A Apolipoprotein ciii in pre- and type 2 diabetes
EP2976070B1 (en) * 2013-03-19 2021-05-12 Lycored Ltd. Anti-inflammatory synergistic combinations of astaxanthin with lycopene and carnosic acid
US9901562B2 (en) * 2013-04-04 2018-02-27 Lycored Ltd. Anti-inflammatory omega-3 synergistic combinations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000060417A (ja) * 1998-02-13 2000-02-29 Soc Prod Nestle Sa トッピング付きト―スト
JP2013510095A (ja) * 2009-11-06 2013-03-21 アルコン リサーチ， リミテッド ドライアイの軽減のための栄養サプリメント

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"丸干しイワシでオイルサーディン", 楽天レシピ, JPN6017046842, 9 April 2012 (2012-04-09), ISSN: 0003697213 *
FREE RADIC. BIOL. MED., 2012, VOL.53, NO.7, PP.1381-1391, JPN6017046848, ISSN: 0003844710 *
JPN. J. CANCER RES., 1997, VOL.88, NO.3, PP.234-237, JPN6017046845, ISSN: 0003844709 *
MOL. NUTR. FOOD RES., 2012, VOL.56, NO.10, PP.1520-1531, JPN6017046844, ISSN: 0003844708 *

Also Published As

Publication number Publication date
EP2981256B1 (en) 2022-08-24
AU2014246728A1 (en) 2015-10-29
EP2981256A4 (en) 2016-11-23
US20160303063A1 (en) 2016-10-20
US20180153843A1 (en) 2018-06-07
WO2014162313A1 (en) 2014-10-09
EP2981256A1 (en) 2016-02-10
US9901562B2 (en) 2018-02-27
CN105407885B (zh) 2019-04-30
US10154980B2 (en) 2018-12-18
JP6803898B2 (ja) 2020-12-23
ES2932248T3 (es) 2023-01-17
CN105407885A (zh) 2016-03-16
AU2014246728B2 (en) 2019-01-31
JP2019052168A (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
JP6636108B2 (ja) アスタキサンチン抗炎症性相乗的組み合わせ
JP6803898B2 (ja) オメガ−３脂肪酸およびトマトリコペンを含む抗炎症性相乗的組み合わせ
KR20190073365A (ko) 사이토카인 과분비 및 바이러스성 감염의 치료를 위한 비만 세포 안정화제
CN106659729A (zh) 烟酰胺单核苷酸在制备防治动脉硬化、心脑血管疾病的药物中的应用及其药物
RU2625797C2 (ru) Использование 3-n-бутил изоиндолин кетонов при приготовлении лекарственных средств для профилактики и лечения церебрального инфаркта
JP2014221735A (ja) ショウガオール類を有効成分として含有する肝細胞活性化剤、並びに該肝細胞活性化剤を含有する固形製剤、液状製剤及び機能性食品
EP4228642A1 (en) Administration of antipurinergic compositions for treating nervous system disorders
WO2020021543A1 (en) Cannabidiol and curcumin for treating inflammatory diseases
US11707469B2 (en) Production of aspirin-triggered resolvins without the use of aspirin in a dietary omega-3 supplement
CN114980882A (zh) 大麻素和番茄红素抗炎协同组合
CN112022858A (zh) 中药单体化合物组合在改善认知功能中的应用
CN108245510B (zh) 大麻二酚与乙丙酰脲类抗癫痫药物的组合物及其用途
JP2016138082A (ja) 抗疲労薬および抗疲労食品
CA3017093A1 (en) Composition for treating and preventing rheumatoid arthritis

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170329

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20180731